Academic Journal
View in EDS
Linked Full Text

Utilization of an electronic dashboard to improve health maintenance in veterans with IBD receiving biologic therapy.

Bibliographic Details
Title: Utilization of an electronic dashboard to improve health maintenance in veterans with IBD receiving biologic therapy.
Authors: Gaulke C; Carolyn Gaulke is a Clinical Assistant Professor at Upstate Medical University College of Nursing in Syracuse, NY.
Source: The Nurse practitioner [Nurse Pract] 2026 Aug 01; Vol. 51 (8), pp. e1-e6. Date of Electronic Publication: 2026 Jul 28.
Publication Type: Journal Article
Language: English
Journal Info: Publisher: Springhouse Corp Country of Publication: United States NLM ID: 7603663 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8662 (Electronic) Linking ISSN: 03611817 NLM ISO Abbreviation: Nurse Pract Subsets: MEDLINE
Imprint Name(s): Publication: Springhouse, PA : Springhouse Corp.
Original Publication: Trenton, N. J., Medical Media Corp.
MeSH Terms: Inflammatory Bowel Diseases*/drug therapy , Inflammatory Bowel Diseases*/nursing , Biological Products*/therapeutic use , Dashboard Systems*, Humans ; Quality Improvement ; Female ; Male
Abstract: Abstract: Globally, the incidence of inflammatory bowel disease increased by 47.5% between 1990 and 2019. Biologic medications are often used in moderate-to-severe cases of inflammatory bowel disease. These medications suppress the immune system, placing individuals at increased risk of infections, vitamin deficiencies, and other adverse outcomes. This 12-week quality improvement project evaluated the use of an electronic dashboard to improve rates of health maintenance activities in patients diagnosed with inflammatory bowel disease receiving biologic therapies utilizing a Plan-Do-Study-Act design. Baseline data showed laboratory monitoring at 67%, bone density testing at 46%, tuberculosis screening at 54%, and pneumococcal vaccination at 33%. The rate of influenza vaccination for the previous season was 63%. Postimplementation, increases in rates of all five health maintenance activities were seen, with laboratory monitoring at 96%, bone density testing at 96%, tuberculosis screening at 96%, pneumococcal vaccination at 78%, and influenza vaccination at 78%. The care of patients with inflammatory bowel disease is complex and requires commitment from medical professionals to provide up-to-date care. Electronic dashboards can assist with providing this type of care.
(Copyright © 2026 Wolters Kluwer Health, LLC. All rights reserved.)
References: Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019. BMJ Open . 2023;13(3):e065186. doi:10.1136/bmjopen-2022-065186.
Lewis JD, Parlett LE, Jonsson Funk ML, et al. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology . 2023;165(5):1197–1205.e2.
US Department of Veterans Affairs. National center for healthcare and advancement and partnership. May 31, 2022. Accessed April 5, 2026. https://www.va.gov/HEALTHPARTNERSHIPS/updates/CCF/05192022.asp.
Villanacci V, Reggiani-Bonetti L, Salviato T, et al. Histopathology of IBD colitis: a practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica . 2021;113(1):39–53. doi:10.32074/1591-951X-235.
Wan J, Zhou J, Wang Z, et al. Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: insights from the past two years. Chin Med J (Engl) . 2025;138(7):763–776. doi:10.1097/cm9.0000000000003542.
Luzentales-Simpson M, Pang YCF, Zhang A, Sousa JA, Sly LM. Vedolizumab: potential mechanisms of action for reducing pathological inflammation in inflammatory bowel diseases. Front Cell Dev Biol . 2021;9:612830. doi:10.3389/fcell.2021.612830.
Xue J-C, Hou X-T, Zhao Y-W, Yuan S. Biological agents as attractive targets for inflammatory bowel disease therapeutics. Biochim Biophys Acta Mol Basis Dis . 2025;1871(3):167648. doi:10.1016/j.bbadis.2024.167648.
Vitello A, Maida M, Shahini E, et al. Current approaches for monitoring of patients with inflammatory bowel diseases: a narrative review. J Clin Med . 2024;13(4):1008. doi:10.3390/jcm13041008.
Crohn's & Colitis Foundation. Health maintenance checklists. 2024. Accessed April 5, 2025. https://www.crohnscolitisfoundation.org/science-and-professionals/education-resources/health-maintenance-checklists.
Farraye FA, Melmed GY, Lichtenstein GR, et al. ACG Clinical Guideline Update: preventive care in inflammatory bowel disease. Am J Gastroenterol . 2025;120(7):1447–1473. doi:10.14309/ajg.0000000000003541.
Reich J, Wasan S, Farraye FA. Vaccinating patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) . 2016;12(9):540–546.
Stone M, Forster E. S860 Adherence to recommended healthcare maintenance guidelines by IBD providers in a tertiary care center. Am J Gastroenterol . 2021;116:S402. doi:10.14309/01.ajg.0000776972.99167.34.
Office of Disease Prevention and Health Promotion, U.S. Department of Health and Human Services. Increase the proportion of people who get the flu vaccine every year — IID-09. Healthy People 2030. https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/increase-proportion-people-who-get-flu-vaccine-every-year-iid-09.
Kozlicki M, Lynch B, Donoho T, Nichols P, Zuckerman AD. Development and implementation of a laboratory monitoring dashboard to reduce treatment gaps in inflammatory bowel disease. Am J Health Syst Pharm . 2023;80(Suppl 2):S55–S61. doi:10.1093/ajhp/zxac354.
Patel K, Chim Y-L, Grant J, Wascher M, Nathanson A, Canfield S. Development and implementation of clinical outcome measures for automated collection within specialty pharmacy practice. J Manag Care Spec Pharm . 2020;26(7):901–909. doi:10.18553/jmcp.2020.26.7.901.
Shah-Khan SM, Cumberledge J, Shah-Khan SM, Gannon K, Kupec JT. Improving bone mineral density screening in patients with inflammatory bowel disease: a quality improvement report. BMJ Open Qual . 2019;8(3):e000624. doi:10.1136/bmjoq-2019-000624.
Harrison NJ, Lopez AA, Shroder MM, et al. Collection and utilization of patient-reported outcome measures in a colorectal surgery clinic. J Surg Res . 2022;280:515–525. doi:10.1016/j.jss.2022.07.042.
Park B-M. Effects of nurse-led intervention programs based on goal attainment theory: a systematic review and meta-analysis. Healthcare (Basel) . 2021;9(6):699. doi:10.3390/healthcare9060699.
Centers for Disease Control and Prevention. Chronic disease. Updated December 4, 2023. Accessed April 11, 2026. https://www.cdc.gov/chronic-disease/index.html.
Contributed Indexing: Keywords: biologics; electronic dashboard; health maintenance; inflammatory bowel disease
Substance Nomenclature: 0 (Biological Products)
Entry Date(s): Date Created: 20260731 Date Completed: 20260731 Latest Revision: 20260819
Update Code: 20260819
DOI: 10.1097/01.NPR.0000000000000463
PMID: 42535706
Database: MEDLINE
Description
ISSN:1538-8662
DOI:10.1097/01.NPR.0000000000000463